Rapid Weight‑Loss Drug Ozempic Linked to Facial Skin Changes

Ozempic, a GLP‑1 agonist originally approved for type‑2 diabetes, has become popular for its strong weight‑loss effect. Medical reports note that rapid fat loss can deplete sub‑cutaneous fat in the face, leading to a hollow appearance, deeper lines, sagging skin and accentuated bone structure—a condition dubbed “Ozempic Face.” The loss of facial fat reduces elasticity and collagen production, causing faster‑appearing ageing signs, especially in older users who already have less facial fat. While the side effect cannot be fully avoided, awareness of these changes helps patients and clinicians manage expectations and consider supportive skin‑care measures.

The phenomenon has attracted attention on social media, prompting discussions about the aesthetic trade‑off of fast weight loss with Ozempic.